CYTOMX THERAPEUTICS INC (CTMX)

US23284F1057 - Common Stock

0.9828  -0.04 (-3.65%)

After market: 0.9785 0 (-0.44%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
126.62M101.21M53.20M37.30M100.40M
Operating Expenses
119.91M107.70M146.80M153.40M149.00M
Research and Development
87.98M77.68M106.30M114.20M112.90M
Selling, General, and Administrative Expenses
31.93M30.02M40.40M39.20M36.00M
Operating Income
6.71M-6.48M-93.60M-116.00M-48.60M
Interest Income/Expense
8.36M9.84M1.70M300.00K1.80M
Other Income/Expense
-11.00K-30.00K300.00K-100.00K0.00
Non Recurring Items
N/AN/A-7.70MN/AN/A
Income Before Taxes
15.06M3.32M-99.30M-115.90M-46.80M
Income Tax
1.23M3.89M0.000.00-13.90M
Net Income
13.83M-569.00K-99.30M-115.90M-32.90M
EBITDA
8.54M-4.31M-91.20M-113.30M-46.10M
 
Per Share Data
EPS Diluted Total Ops
0.17-0.01-1.51-1.81-0.71
Non GAAP EPS
0.17-0.02-1.52-1.31-0.72
 
Statistics
Profit Margin
10.92%-0.56%-186.65%-310.72%-32.77%
Operating Profit Margin
5.30%-6.41%-175.94%-310.99%-48.41%

All data in USD

Charts